Recurrent translocation t(10;17)(p15;q21) in minimally differentiated acute myeloid leukemia results in ZMYND11/MBTD1 fusion

Genes Chromosomes and Cancer

Volumn 55, Issue 3, 2016, Pages 237-241

  de Rooij, Jasmijn D E ^a   van den Heuvel Eibrink, Marry M ^a,b   Kollen, Wouter J W ^c   Sonneveld, Edwin ^d   Kaspers, Gertjan J L ^e   Beverloo, H Berna ^f,g   Fornerod, Maarten ^a   Pieters, Rob ^b   Zwaan, C Michel ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b University Medical Center Utrecht Princess Máxima Center for Pediatric Oncology   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d Dutch Childhood Oncology Group DCOG   (Netherlands)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^f ERASMUS MEDICAL CENTER   (Netherlands)

^g Dutch Working Group on Hemato Oncologic Genome Diagnostics   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; HISTONE H3; HYBRID PROTEIN; PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR HOXA; UNCLASSIFIED DRUG; ZMYND11 MBTD1 FUSION PROTEIN; CARRIER PROTEIN; MBTD1 PROTEIN, HUMAN; NONHISTONE PROTEIN; NUCLEOPORIN; ONCOPROTEIN; ZMYND11 PROTEIN, HUMAN;

ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CASE REPORT; CHILDHOOD LEUKEMIA; CHROMOSOME 10P; CHROMOSOME 17Q; CHROMOSOME TRANSLOCATION; EXON; GENE EXPRESSION PROFILING; GENE FUSION; HUMAN; HUMAN CELL; LEUKEMIA CELL; MALE; MINIMALLY DIFFERENTIATED ACUTE MYELOBLASTIC LEUKEMIA; PHENOTYPE; PRIORITY JOURNAL; START CODON; TUMOR SUPPRESSOR GENE; ZMYND11 MBTD1 FUSION; ACUTE MYELOID LEUKEMIA; AMINO ACID SEQUENCE; CELL DIFFERENTIATION; CHILD; CHROMOSOME 11; GENE TRANSLOCATION; GENETICS; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE;

AMINO ACID SEQUENCE; BASE SEQUENCE; CARRIER PROTEINS; CELL DIFFERENTIATION; CHILD; CHROMOSOMAL PROTEINS, NON-HISTONE; CHROMOSOMES, HUMAN, PAIR 11; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MOLECULAR SEQUENCE DATA; NUCLEAR PORE COMPLEX PROTEINS; ONCOGENE PROTEINS, FUSION; TRANSLOCATION, GENETIC;

EID: 84954386000     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.22326     Document Type: Article

References (26)

1. Alharbi RA, Pettengell R, Pandha HS, Morgan R. 2013. The role of HOX genes in normal hematopoiesis and acute leukemia. Leukemia 27:1000-1008.
2. Andreeff M, Ruvolo V, Gadgil S, Zeng C, Coombes K, Chen W, Kornblau S, Baron AE, Drabkin HA. 2008. HOX expression patterns identify a common signature for favorable AML. Leukemia 22:2041-2047.
3. Balgobind BV, Hollink IH, Arentsen-Peters ST, Zimmermann M, Harbott J, Beverloo HB, von Bergh AR, Cloos J, Kaspers GJ, de Haas V, Zemanova Z, Stary J, Cayuela JM, Baruchel A, Creutzig U, Reinhardt D, Pieters R, Zwaan CM, van den Heuvel-Eibrink MM. 2011. Integrative analysis of type-I and type-II aberrations underscores the genetic heterogeneity of pediatric acute myeloid leukemia. Haematologica 96:1478-1487.
4. Chen CW, Armstrong SA. 2015. Targeting DOT1L and HOX gene expression in MLL-rearranged leukemia and beyond. Exp Hematol 43:673-684.
5. Coenen EA, Zwaan CM, Reinhardt D, Harrison CJ, Haas OA, de Haas V, Mihal V, De Moerloose B, Jeison M, Rubnitz JE, Tomizawa D, Johnston D, Alonzo TA, Hasle H, Auvrignon A, Dworzak M, Pession A, van der Velden VH, Swansbury J, Wong KF, Terui K, Savasan S, Winstanley M, Vaitkeviciene G, Zimmermann M, Pieters R, van den Heuvel-Eibrink MM. 2013. Pediatric acute myeloid leukemia with t(8;16)(p11;p13), a distinct clinical and biological entity: A collaborative study by the International-Berlin-Frankfurt-Munster AML-study group. Blood 122:2704-2713.
6. De Braekeleer E, Auffret R, Douet-Guilbert N, Basinko A, Le Bris MJ, Morel F, De Braekeleer M. 2014. Recurrent translocation (10;17)(p15;q21) in acute poorly differentiated myeloid leukemia likely results in ZMYND11-MBTD1 fusion. Leuk Lymphoma 55:1189-1190.
7. De Braekeleer E, Douet-Guilbert N, Basinko A, Le Bris MJ, Morel F, De Braekeleer M. 2014. Hox gene dysregulation in acute myeloid leukemia. Future Oncol 10:475-495.
8. de Rooij JD, Hollink IH, Arentsen-Peters ST, van Galen JF, Berna Beverloo H, Baruchel A, Trka J, Reinhardt D, Sonneveld E, Zimmermann M, Alonzo TA, Pieters R, Meshinchi S, van den Heuvel-Eibrink MM, Zwaan CM. 2013. NUP98/JARID1A is a novel recurrent abnormality in pediatric acute megakaryoblastic leukemia with a distinct HOX gene expression pattern. Leukemia 27:2280-2288.
9. De Rooij JD, Zwaan CM, van den Heuvel-Eibrink MM. 2015. Pediatric AML: From Biology to Clinical Management. J Clin Med 4:127-149.
10. Eryilmaz J, Pan P, Amaya MF, Allali-Hassani A, Dong A, Adams-Cioaba MA, Mackenzie F, Vedadi M, Min J. 2009. Structural studies of a four-MBT repeat protein MBTD1. PLoS One 4:e7274
11. Hollink IH, van den Heuvel-Eibrink MM, Arentsen-Peters ST, Pratcorona M, Abbas S, Kuipers JE, van Galen JF, Beverloo HB, Sonneveld E, Kaspers GJ, Trka J, Baruchel A, Zimmermann M, Creutzig U, Reinhardt D, Pieters R, Valk PJ, Zwaan CM. 2011. NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern. Blood 118:3645-3656.
12. Hollink IH, Zwaan CM, Zimmermann M, Arentsen-Peters TC, Pieters R, Cloos J, Kaspers GJ, de Graaf SS, Harbott J, Creutzig U, Reinhardt D, van den Heuvel-Eibrink MM, Thiede C. 2009. Favorable prognostic impact of NPM1 gene mutations in childhood acute myeloid leukemia, with emphasis on cytogenetically normal AML. Leukemia 23:262-270.
13. Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL and Yu M. based on November 2013 SEER data submission, posted to the SEER web site, April 2014. SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD. Available at: http://seer.cancer.gov/csr/1975_2011/.
14. Kaspers GJ, Veerman AJ, Pieters R, Broekema GJ, Huismans DR, Kazemier KM, Loonen AH, Rottier MA, van Zantwijk CH, Hahlen K, Van Wering ER. 1994. Mononuclear cells contaminating acute lymphoblastic leukaemic samples tested for cellular drug resistance using the methyl-thiazol-tetrazolium assay. Br J Cancer 70:1047-1052.
15. Kaspers GJ, Zwaan CM. 2007. Pediatric acute myeloid leukemia: Towards high-quality cure of all patients. Haematologica 92:1519-1532.
16. Klymenko T, Papp B, Fischle W, Kocher T, Schelder M, Fritsch C, Wild B, Wilm M, Muller J. 2006. A Polycomb group protein complex with sequence-specific DNA-binding and selective methyl-lysine-binding activities. Genes Dev 20:1110-1122.
17. Maurer-Stroh S, Dickens NJ, Hughes-Davies L, Kouzarides T, Eisenhaber F, Ponting CP. 2003. The Tudor domain 'Royal Family': Tudor, plant Agenet, Chromo, PWWP and MBT domains. Trends Biochem Sci 28:69-74.
18. Mitelman F, Johansson B, Mertens F. 2015. Available at: http://cgap.nci.nih.gov/Chromosomes/Mitelman. Mitelman Database of Chromosome Aberrations and Gene Fusions in Cancer.
19. Nady N, Krichevsky L, Zhong N, Duan S, Tempel W, Amaya MF, Ravichandran M, Arrowsmith CH. 2012. Histone recognition by human malignant brain tumor domains. J Mol Biol 423:702-718.
20. Pui CH, Carroll WL, Meshinchi S, Arceci RJ. 2011. Biology, risk stratification, and therapy of pediatric acute leukemias: An update. J Clin Oncol 29:551-565.
21. Skvarova Kramarzova K, Fiser K, Mejstrikova E, Rejlova K, Zaliova M, Fornerod M, Drabkin HA, van den Heuvel-Eibrink MM, Stary J, Trka J, Starkova J. 2014. Homeobox gene expression in acute myeloid leukemia is linked to typical underlying molecular aberrations. J Hematol Oncol 7:94
22. Tempescul A, Guillerm G, Douet-Guilbert N, Morel F, Le Bris MJ, De Braekeleer M. 2007. Translocation (10;17)(p15;q21) is a recurrent anomaly in acute myeloblastic leukemia. Cancer Genet Cytogenet 172:74-76.
23. Trojer P, Li G, Sims RJ, 3rd Vaquero A, Kalakonda N, Boccuni P, Lee D, Erdjument-Bromage H, Tempst P, Nimer SD, Wang YH, Reinberg D. 2007. L3MBTL1, a histone-methylation-dependent chromatin lock. Cell 129:915-928.
24. Wang GG, Cai L, Pasillas MP, Kamps MP. 2007. NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis. Nat Cell Biol 9:804-812.
25. Wen H, Li Y, Li H, Shi X. 2014a. ZMYND11: An H3.3-specific reader of H3K36me3. Cell Cycle 13:2153-2154.
26. Wen H, Li Y, Xi Y, Jiang S, Stratton S, Peng D, Tanaka K, Ren Y, Xia Z, Wu J, Li B, Barton MC, Li W, Li H, Shi X. 2014b. ZMYND11 links histone H3.3K36me3 to transcription elongation and tumour suppression. Nature 508:263-268.